Skip to main content

STRIVE Post-Market Registry Study

Recruiting · NCT04302272

Conditions: Emphysema

At a glance

Research payments reported, 2025
$341,933
U.S. investigators named
9
Sites paid
8
Planned or actual enrollment
150

About the trial

Sponsor
Olympus Corporation of the Americas
Tested
Spiration Valve System (SVS) (device)
Dates
Started 2021-10-09; completion 2029-10
Results posted
Not yet

This is a single-arm, prospective, multi-center, Registry study to evaluate the long-term safety and effectiveness of the Spiration Valve System (SVS) for the treatment of severe emphysema in a post-market setting.

From ClinicalTrials.gov, last updated 2026-10-16. Full record, eligibility and contacts (opens in a new tab)

Industry funding

Gyrus Acmi, Inc. reported $341,933 in research payments for this study in 2025 (43 payments).

Products named: Spiration Valve System

Research payments usually go to hospitals, universities and research sites to run a study, not to the investigators personally. A payment is not evidence of wrongdoing.

U.S. investigators named on this study

Clinicians the company named as principal investigators in its Open Payments reports.

Sites paid to run it

Sources: CMS Open Payments research payments (program year 2025) and ClinicalTrials.gov, U.S. National Library of Medicine.